Positron emission tomography with the application of 18F-fluorodeoxyglucose in the differential diagnostics of neurodegenerative diseases with the cognitive impairment and role of amyloid beta specific radiopharmaceutical in Alzheimer disease confirmation
Česká radiologie · 01.06.2024 · 78 (2) · 77-89
DOI: 10.55095/cesradiol2024/011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Česká radiologie, erschienen am 01.06.2024. Verfasst von Jiří Ferda und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
18F-FDG-PET zobrazen u nemocnch s neurodegenerativnmi onemocnnmi jenejvhodnj metodou k rozpoznn jednotlivch typ neurodegenerac.Jednotliv typy onemocnn nebo jejich skupiny vykazuj specifick vzorce distribuce hypometabolismu- lze tak odliit zejmna frontotemporln degeneraci od demence s Lewyhotlsky a od Alzheimerovy nemoci, a dle onemocnn charakterizovan poruchamivyjadovn ze skupiny primrn progresivn afzie nebo onemocnn s poruchamipohybu typu kortikobazln degenerace. Doplujc zobrazen s pomoc amyloidspecifickch ltek pak slou k potvrzen ptomnosti amyloidu beta vkortikln ed hmot u nemocnch Alzheimerovou chorobou.
Zitieren
APA
Ferda, J., & Ferdová, E. (2024). Positron emission tomography with the application of 18F-fluorodeoxyglucose in the differential diagnostics of neurodegenerative diseases with the cognitive impairment and role of amyloid beta specific radiopharmaceutical in Alzheimer disease confirmation. Česká radiologie, 78(2), 77-89. https://doi.org/10.55095/cesradiol2024/011
Vancouver
Ferda J, Ferdová E. Positron emission tomography with the application of 18F-fluorodeoxyglucose in the differential diagnostics of neurodegenerative diseases with the cognitive impairment and role of amyloid beta specific radiopharmaceutical in Alzheimer disease confirmation. Česká radiologie. 2024;78(2):77-89. doi:10.55095/cesradiol2024/011
BibTeX
@article{Ferda2024,
author = {Ferda, Jiří and Ferdová, Eva},
title = {Positron emission tomography with the application of 18F-fluorodeoxyglucose in the differential diagnostics of neurodegenerative diseases with the cognitive impairment and role of amyloid beta specific radiopharmaceutical in Alzheimer disease confirmation},
journal = {Česká radiologie},
year = {2024},
volume = {78},
number = {2},
pages = {77--89},
doi = {10.55095/cesradiol2024/011}
}
EUVIMED